Humana Inc. Stock

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-06-24 pm EDT 5-day change 1st Jan Change
358 USD +0.72% Intraday chart for Humana Inc. +0.79% -21.79%
Sales 2024 * 114B Sales 2025 * 115B Capitalization 43.14B
Net income 2024 * 1.8B Net income 2025 * 2.33B EV / Sales 2024 * 0.43 x
Net Debt 2024 * 5.31B Net Debt 2025 * 4.94B EV / Sales 2025 * 0.42 x
P/E ratio 2024 *
23.7 x
P/E ratio 2025 *
18.2 x
Employees 67,600
Yield 2024 *
1.03%
Yield 2025 *
1.09%
Free-Float 60.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.72%
1 week+0.79%
Current month-0.02%
1 month+2.50%
3 months+2.73%
6 months-21.00%
Current year-21.79%
More quotes
1 week
349.55
Extreme 349.55
360.54
1 month
328.09
Extreme 328.09
365.50
Current year
298.61
Extreme 298.6063
475.00
1 year
298.61
Extreme 298.6063
530.54
3 years
298.61
Extreme 298.6063
571.30
5 years
208.25
Extreme 208.25
571.30
10 years
115.51
Extreme 115.51
571.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 11-11-30
Director of Finance/CFO 50 05-12-31
Chief Administrative Officer 57 12-11-30
Members of the board TitleAgeSince
Director/Board Member 60 22-08-31
Chairman 63 03-06-30
Director/Board Member 67 19-09-22
More insiders
Date Price Change Volume
24-06-24 358 +0.72% 1,441,673
24-06-21 355.5 -0.54% 1,633,238
24-06-20 357.4 +2.25% 1,473,581
24-06-18 349.6 -1.60% 693,495

Delayed Quote Nyse, June 24, 2024 at 04:00 pm EDT

More quotes
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
358 USD
Average target price
374 USD
Spread / Average Target
+4.45%
Consensus